VITA 34 AG

XTRA:V3V Rapporto sulle azioni

Cap. di mercato: €78.4m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

VITA 34 Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jakub Baran

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.4yrs
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione4.1yrs

Aggiornamenti recenti sulla gestione

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Recent updates

Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Apr 04
Why We're Not Concerned About VITA 34 AG's (ETR:V3V) Share Price

Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Dec 24
Revenues Tell The Story For VITA 34 AG (ETR:V3V) As Its Stock Soars 26%

Is VITA 34 (ETR:V3V) Using Too Much Debt?

Nov 23
Is VITA 34 (ETR:V3V) Using Too Much Debt?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Jul 15
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Feb 17
Is VITA 34 (ETR:V3V) Using Debt In A Risky Way?

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Apr 08
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Dec 07
VITA 34 AG's (ETR:V3V) CEO Compensation Looks Acceptable To Us And Here's Why

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

May 12
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: VITA 34 AG Missed EPS By 29% And Analysts Are Revising Their Forecasts

VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Mar 25
VITA 34 AG's (ETR:V3V) Intrinsic Value Is Potentially 56% Above Its Share Price

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Mar 10
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Feb 22
Here's Why VITA 34 (ETR:V3V) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Feb 05
Is It Too Late To Consider Buying VITA 34 AG (ETR:V3V)?

Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Jan 18
Can Mixed Financials Have A Negative Impact on VITA 34 AG's 's (ETR:V3V) Current Price Momentum?

Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

Jan 02
Did You Participate In Any Of VITA 34's (ETR:V3V) Fantastic 201% Return ?

How Is VITA 34's (ETR:V3V) CEO Compensated?

Dec 18
How Is VITA 34's (ETR:V3V) CEO Compensated?

Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

Dec 01
Should You Be Adding VITA 34 (ETR:V3V) To Your Watchlist Today?

AMMINISTRATORE DELEGATO

Jakub Baran

2.4yrs

Mandato

Mr. Jakub Julian Baran serves as Chairman of the Management Board and Chief Executive Officer at VITA 34 AG since March 22, 2022. He serves as Member of the Supervisory Board at Betacom S.A. since May 2019...

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Isadore Ances
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
A. Bader
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Robert Iannone
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
W. Holzgreve
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Carlo Croce
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Jack Goldberg
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
E. Wunder
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Ronald Wapner
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Zbigniew Mrowiec
Member of Scientific & Medical Advisory Boardno dataNessun datoNessun dato
Florian Schuhbauer
Deputy Chairman of the Supervisory Board4.1yrs€20.00kNessun dato
Alexander Granderath
Chairman of Supervisory Board2.7yrsNessun datoNessun dato
Frank Kohler
Independent Member of the Supervisory Board7.2yrs€30.00kNessun dato

4.1yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di V3V sono considerati esperti (durata media dell'incarico 4.1 anni).